Clinical resource
Prostate adenocarcinoma definitive ultra-hypofractionated stereotactic EBRT (eviQ ID 4140)
eviQ, Cancer Institute NSW
DoseLab summary
Endorsed eviQ protocol for prostate SBRT. DoseLab's prostate SBRT constraint table reproduces selected values from its organs-at-risk table, keeping eviQ's citation for each.
Why this is useful
Five-fraction prostate SBRT constraints drawn mainly from PACE-B and the TROG NINJA trial, including urethral PRV limits.
Reference details
- Title
- Prostate adenocarcinoma definitive ultra-hypofractionated stereotactic EBRT (eviQ ID 4140)
- Authors / organization
- eviQ, Cancer Institute NSW
- Publication / protocol
- eviQ Radiation Oncology protocol 4140
- Version
- v.2 — last reviewed 7 November 2024; review due 31 December 2026
- Year
- 2024
- DOI
- Pending verification
- Disease sites
- Prostate
- Topics
- Prostate, SBRT, Dose Constraints, Protocols
- Fractionation context
- 36.25 Gy/5 fx to PTV (40 Gy to CTV)
- Last reviewed by DoseLab
- 2026-09-22